Caio Max Rocha Lima to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Caio Max Rocha Lima has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.162
-
Rocha Lima CM, Joppert MG. Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer. Oncology (Williston Park). 2002 Sep; 16(9 Suppl 9):25-31.
Score: 0.053
-
Rocha Lima CM, Herndon JE, Kosty M, Clamon G, Green MR. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer. 2002 Jan 01; 94(1):181-7.
Score: 0.050
-
Green MR, Harper M, Safa A, Sherman CA, Mushtaq CM, Bahadori H, Brescia FJ, Rocha Lima CM. Irinotecan in the management of patients with pancreatic cancer. Oncology (Williston Park). 2000 Dec; 14(12 Suppl 14):31-3.
Score: 0.047
-
Cappuzzo F, Rocha Lima CM, Sherman CA, Green MR. Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative. Oncology (Williston Park). 2000 Jul; 14(7 Suppl 4):7-14.
Score: 0.011